NL-OMON26666招募中不适用
Randomised, controlled, open label, cross-over trial to evaluate the tolerance of a new paediatric sip feed in children in need of oral nutritional support.
Danone Research – Centre for Specialised Nutrition0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 28
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male and female subjects, aged 3-12 years (including 3 and 12 years) in need of oral nutritional support (subject can be current or new paediatric sip feed user);
- •2. Subject requires a paediatric sip feed for at least 6 weeks;
排除标准
- •1. Cow’s milk allergy, known inflammatory bowel diseases, bowel resection;
- •2. Subjects requiring a fibre-free diet;
研究者
相似试验
尚未招募
2 期
Randomised, controlled, open label, cross-over trial to evaluate the tolerance of a new smoothie-style paediatric sip feed in children in need of oral nutritional support.ondervoeding en andere redenen waarom een kind niet (genoeg) groeit.Failure to thriveMalnutrition10003018NL-OMON34977Danone Research - Centre for Specialised Nutrition19
进行中（未招募）
不适用
An Open-label, Randomised, Three -Way, Cross-Over Study to Assess the Pharmacokinetics, Safety and Tolerability of Two Formulations of RBP-6300 10mg in Healthy Volunteers under a Naltrexone Block in the Presence and Absence of Food.Maintenance/substitution agent for the treatment of opioid dependence.MedDRA version: 16.0Level: LLTClassification code 10012346Term: Dependence on opiatesSystem Organ Class: 100000004873EUCTR2012-002408-42-GBReckitt Benckiser Pharmaceuticals Inc.
已完成
1 期
A three-dose study of N-Acetyl-D-Mannosamine Monohydrate (ManNAc) in fasting conditions to determine the difference in absorption when dosed differently in healthy male participantsGNE MyopathyMusculoskeletal - Other muscular and skeletal disordersHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersACTRN12620001127998niversity of South Australia12
已完成
Unknown
A study to examine the comparative exposure of N-Acetyl-D-Mannosamine Monohydrate (ManNAc) when administered orally as a solution and two novel tablet formulations in healthy adult malesGNE MyopathyMusculoskeletal - Other muscular and skeletal disordersHereditary Inclusion Body MyopathyACTRN12623000609651niversity of South Australia6
已完成
2 期
Bioavailability study on Healthy subjectsCTRI/2024/04/066202Botanic Healthcare Pvt Ltd12